Ever Supreme Bio Technology Co

Ever Supreme Bio Technology Co EBIT

The EBIT of Ever Supreme Bio Technology Co (6712.TWO) as of Oct 18, 2026 is 438.94 M TWD. In the previous year, EBIT was 465.64 M TWD — a change of -5.73% (lower).

EBIT

438.94 MTWD

YoY

-5.73%

Last updated:

In 2025, Ever Supreme Bio Technology Co's EBIT was 438.94 M TWD, a -5.73% increase from the 465.64 M TWD EBIT recorded in the previous year.

The Ever Supreme Bio Technology Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2020
-136.62 M TWD
Jan 1, 2021
397.44 M TWD
Jan 1, 2022
264.61 M TWD
Jan 1, 2023
623.22 M TWD
Jan 1, 2024
465.64 M TWD
Jan 1, 2025
438.94 M TWD
Jan 1, 2026 (e)
562.36 M TWD
Jan 1, 2027 (e)
604.53 M TWD
The Ever Supreme Bio Technology Co EBIT history
YEAREBITYoY
est604.53 MTWD+7.50%
est562.36 MTWD+28.12%
438.94 MTWD-5.73%
465.64 MTWD-25.28%
623.22 MTWD+135.52%
264.61 MTWD-33.42%
397.44 MTWD-390.91%
-136.62 MTWD+0.84%
-135.49 MTWD+44.49%
-93.77 MTWD+134.73%
-39.95 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Supreme Bio Technology Co Revenue

Ever Supreme Bio Technology Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
70.60 M TWD
-136.62 M TWD
-106.83 M TWD
Jan 1, 2021
438.84 M TWD
397.44 M TWD
369.60 M TWD
Jan 1, 2022
627.51 M TWD
264.61 M TWD
200.71 M TWD
Jan 1, 2023
758.39 M TWD
623.22 M TWD
539.40 M TWD
Jan 1, 2024
933.81 M TWD
465.64 M TWD
367.25 M TWD
Jan 1, 2025
1.02 B TWD
438.94 M TWD
429.43 M TWD
Jan 1, 2026 (e)
1.20 B TWD
562.36 M TWD
516.58 M TWD
Jan 1, 2027 (e)
1.39 B TWD
604.53 M TWD
555.35 M TWD

Ever Supreme Bio Technology Co Margins

Ever Supreme Bio Technology Co stock margins

The Ever Supreme Bio Technology Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ever Supreme Bio Technology Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ever Supreme Bio Technology Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
-25.42 %
-193.52 %
-151.32 %
Jan 1, 2021
55.94 %
90.57 %
84.22 %
Jan 1, 2022
66.06 %
42.17 %
31.99 %
Jan 1, 2023
63.92 %
82.18 %
71.12 %
Jan 1, 2024
70.68 %
49.86 %
39.33 %
Jan 1, 2025
70.89 %
43.14 %
42.20 %
Jan 1, 2026 (e)
70.89 %
46.82 %
43.01 %
Jan 1, 2027 (e)
70.89 %
43.55 %
40.01 %

Ever Supreme Bio Technology Co Stock analysis

What does Ever Supreme Bio Technology Co do? Ever Supreme Bio Technology Co Ltd is a biotechnology company based in Taichung, Taiwan, operating within the healthcare sector. The company has 8 employees and went public on October 26, 2018. It focuses on the research, development, and sale of stem cell products. The company's website is https://www.ever-supreme.com.tw/. Ever Supreme Bio Technology Co Ltd is engaged in the development of stem cell-based therapies, with specific products including ADCV01, a dendritic cell tumor vaccine currently in Phase II clinical trials in Taiwan. The company also develops UMSC01, a human allogeneic umbilical cord stem cell product intended for the treatment of myocardial infarction. UMSC01 is approved for Phase I clinical trials by the U.S. Food and Drug Administration (FDA) and is undergoing regulatory processes in Taiwan. Additionally, the company is involved in the development of stem cell treatments for acute ischemic stroke, with clinical Phase I trials pending in the United States. The company has plans to expand its product portfolio to include mesenchymal stem cells for multiple sclerosis treatment. Ever Supreme Bio Technology Co Ltd is listed on the Taiwan Stock Exchange under ticker 6712.TWO with ISIN TW0006712003. The company's operations are centered around innovative biotechnology solutions aimed at addressing critical healthcare needs. Ever Supreme Bio Technology Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Ever Supreme Bio Technology Co's EBIT

Ever Supreme Bio Technology Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Ever Supreme Bio Technology Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Ever Supreme Bio Technology Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Ever Supreme Bio Technology Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Ever Supreme Bio Technology Co stock

EBIT of Ever Supreme Bio Technology Co is 438.94 M TWD in 2025.

EBIT of Ever Supreme Bio Technology Co changed from 465.64 M TWD to 438.94 M TWD, representing a -5.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Ever Supreme Bio Technology Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Ever Supreme Bio Technology Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ever Supreme Bio Technology Co

All Key Metrics — Ever Supreme Bio Technology Co